Primary Recipient

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON

Amount

$619,988.00

Award Date

5/13/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Cyclooxygenase (COX) inhibitors lower the risk of colorectal cancer (CRC) and inhibit tumor growth in animal and cell culture models. However, their efficacy in treating existing CRC remains controversial. Previous research in our laboratory has demonstra

Recipients Connected to Award

Recipient	Role	Amount
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON	Primary recipient	$598,040.00
UNIVERSITY OF KENTUCKY	Sub-recipient	$21,948.00